A curable composition and a method for adhering substrates with the same

US2022389295A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022389295-A1
Application numberUS-201917767108-A
CountryUS
Kind codeA1
Filing dateNov 15, 2019
Priority dateNov 15, 2019
Publication dateDec 8, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described is a curable composition, and particularly a two-component composition comprising a silane modified polymer; an epoxy resin terminated with epoxy terminal group; wherein the composition further comprises a hardening agent and a compatibilizer which has at least one silane group and at least one epoxy terminal group. The curable composition exhibits enhanced adhesion strength and good elongation at break. A method for applying the curable composition on the surface of a substrate is also provided.

First claim

Opening claim text (preview).

1 . A curable composition, comprising at least one silane modified polymer; at least one epoxy resin terminated with epoxy group; wherein the composition further comprises a hardening agent, and a compatibilizer which has at least one silane group and at least one epoxy terminal group. 2 . The curable composition according to claim 1 , wherein the curable composition is a two-component curable composition comprising a component A and a component B, wherein the silane modified polymer and the hardening agent are contained in the component A, and the epoxy resin and the compatibilizer are contained in the component B. 3 . The curable composition according to claim 1 , wherein the silane modified polymer is represented by formula I: R 1 m (R 2 O) (3-m) Si—R 7 -(polymeric main chain)-R 8 —SiR 3 n (R 4 O) (3-n)   Formula I wherein the polymeric main chain is derived from a polyol, or derived from at least one polyisocyanate and at least one polyol, and is optionally functionalized with at least one —R 9 —SiR 5 s (R 6 O) (3-s) , each of R 1 , and R 6 independently represents a hydrogen atom or a C 1 -C 6 alkyl group, each of m, n and s represents an integrate of 0, 1 or 2, each of R 7 , R 8 and R 9 independently represents a direct bond, —O—, a divalent (C 1 to C 6 alkylene) group, —O—(C 1 to C 6 alkylene) group, (C 1 to C 6 alkylene)-O— group, —O—(C 1 to C 6 alkylene)-O— group, —N(R N )—(C 1 to C 6 alkylene) group or —C(═O)—N(R N )—(C 1 to C 6 alkylene) group, wherein R N represents a hydrogen atom or a C 1 -C 6 alkyl group. 4 . The curable composition according to claim 3 , wherein the polymeric main chain is derived from polyether polyol, polyester polyol, or copolymer thereof. 5 . The curable composition according to claim 1 , wherein the compatibilizer is a compound represented by formula II, or a condensation oligomer/polymer thereof: wherein R 10 is selected a group consisting of wherein * represents the linkage site, R 11 is selected from a group consisting of C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene, —C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene, —C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 [O—Si(C 1 -C 6 alkyl) 2 ] x -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, and —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -[O—Si(C 1 -C 6 alkoxy) 2 ] x -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, wherein each of R 12 and R 13 independently represents a hydrogen atom or a C 1 -C 6 alkyl group optionally substituted with C 1 -C 6 alkyl group, C 1 -C 6 alkoxy group, halogen atom, C 2 -C 6 alkeny group, C 2 -C 6 alkynyl group, —Si(C 1 -C 4 alkyl) 3 , —Si(C 1 -C 4 alkoxy) 3 , —Si—{O—[Si(C 1 -C 4 alkoxy) 3 ] 3 , —(C 1 -C 6 )alkylene-Si(C 1 -C 4 alkyl) 3 , —(C 1 -C 6 )alkylene —Si(C 1 -C 4 alkoxy) 3 or —(C 1 -C 6 )alkylene-Si—{O—[Si(C 1 -C 4 alkoxy) 3 ] 3 , t represents an integer of 0, 1 or 2, and x represents an integer of 1 to 100. 6 . The curable composition according to claim 5 , wherein the compatibilizer is a condensation oligomer or condensation polymer represented by formula III, wherein R 10 is selected a group consisting of wherein * represents the linkage site, R 11 is selected from a group consisting of C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene, —C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene, —C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -[O—Si(C 1 -C 6 alkyl) 2 ] x -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, and —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -[O—Si(C 1 -C 6 alkoxy) 2 ] x -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, R 13 represents a hydrogen atom or a C 1 -C 6 alkyl group optionally substituted with C 1 -C 6 alkyl group, C 1 -C 6 alkoxy group, halogen atom, C 2 -C 6 alkeny group, C 2 -C 6 alkynyl group, —Si(C 1 -C 4 alkyl) 3 , —Si(C 1 -C 4 alkoxy) 3 , —Si—{O—[Si(C 1 -C 4 alkoxy) 3 ] 3 , —(C 1 -C 6 )alkylene-Si(C 1 -C 4 alkyl) 3 , —(C 1 -C 6 )alkylene —Si(C 1 -C 4 alkoxy) 3 or —(C 1 -C 6 )alkylene-Si—{O—[Si(C 1 -C 4 alkoxy) 3 ] 3 , r represents an integer of 1 to 50, and x represents an integer of 1 to 100. 7 . The curable composition according to claim 1 , wherein the compatibilizer is selected from a group consisting of wherein x represents an integer of 1 to 100, wherein R′ is selected from a group consisting of C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene, —C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene, —C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkyl) 2 [O—Si(C 1 -C 6 alkyl) 2 ] x -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, and —(CH 2 —O)—C 2 -C 6 alkylene-Si(C 1 -C 6 alkoxy) 2 -[O—Si(C 1 -C 6 alkoxy) 2 ] x -C 2 -C 6 alkylene-(O—CH 2 )—CH(OH)—CH 2 —NH—C 2 -C 6 alkylene, R represents a hydrogen atom or a C 1 -C 6 alkyl group optionally substituted with C 1 -C 6 alkyl group, C 1 -C 6 alkoxy group, halogen atom, C 2 -C 6 alkeny group, C 2 -C 6 alkynyl group, —Si(C 1 -C 4 alkyl) 4 , —Si(C 1 -C 4 alkoxy) 3 , —Si—{O—[Si(C 1 -C 4 alkoxy) 4 ] 3 , —(C 1 -C 6 )alkylene-Si(C 1 -C 4 alkyl) 3 , —(C 1 -C 6 )alkylene —Si(C 1 -C 4 alkoxy) 3 or —(C 1 -C 6 )alkylene-Si—{O—[Si(C 1 -C 4 alkoxy) 3 ] 3 , and y represents an integer of 1 to 50. 8 . The curable composition according to claim 3 , wherein the polymeric main chain is derived from a polyol, or derived from at least one polyisocyanate and at least one polyol, the polyisocyanate is selected from the group consisting of C 4 -C 12 aliphatic polyisocyanate comprising at least two isocyanate groups, C 6 -C 15 cycloaliphatic or aromatic polyisocyanate comprising at least two isocyanate groups, C 7 -C 15 araliphatic polyisocyanate comprising at least two is

Assignees

Inventors

Classifications

  • C09J163/00Primary

    Adhesives based on epoxy resins; Adhesives based on derivatives of epoxy resins · CPC title

  • without carriers · CPC title

  • additives as essential feature of the adhesive layer · CPC title

  • C09J183/14Primary

    in which at least two but not all the silicon atoms are connected by linkages other than oxygen atoms (C09J183/10 takes precedence) · CPC title

  • Polysiloxanes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022389295A1 cover?
Described is a curable composition, and particularly a two-component composition comprising a silane modified polymer; an epoxy resin terminated with epoxy terminal group; wherein the composition further comprises a hardening agent and a compatibilizer which has at least one silane group and at least one epoxy terminal group. The curable composition exhibits enhanced adhesion strength and good …
Who is the assignee on this patent?
Dow Global Technologies Llc
What technology area does this patent fall under?
Primary CPC classification C09J163/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).